Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky.
| Revenue (TTM) | $137.20B |
| Gross Profit (TTM) | $19.22B |
| EBITDA | $3.36B |
| Operating Margin | 4.67% |
| Return on Equity | 6.28% |
| Return on Assets | 3.64% |
| Revenue/Share (TTM) | $1139.81 |
| Book Value | $154.75 |
| Price-to-Book | 2.56 |
| Price-to-Sales (TTM) | 0.35 |
| EV/Revenue | 0.413 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -4.60% |
| Quarterly Revenue Growth (YoY) | 23.50% |
| Shares Outstanding | $120.06M |
| Float | $119.81M |
| % Insiders | 0.21% |
| % Institutions | 99.88% |
Volatility is currently contracting
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide. The 2026 national grants scale the Foundati.
CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.
Swedish care provider Ambea said on Monday it had made a recommended public offer for peer Humana , valuing the company at about 2.96 billion Swedish crowns ($304.13 million).
HUM is shifting from membership growth to profitability, with lower medical costs, rising CenterWell revenues, and a margin recovery plan through 2028.
SAN FRANCISCO, June 23, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Humana Inc. (NYSE: HUM) investors that the firm is investigating potential legal claims arising from alleged false and misleading statements about the company's exposure to increased healthcare utilization costs. Current shareholders are encouraged to contact the firm here: https://www.classactionlawyers.com/humana.
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 2Q26 earnings call may be accessed via Humana's Investor Relations page at h.
UNH's diversified platform, AI investments and stronger earnings outlook give it an edge over Medicare-focused rival HUM.
Until recently, it had been a lackluster year for the healthcare sector. From high medical utilization squeezing insurers to structural cost pressures and valuation hangovers, medical stocks stocks have lagged much of the broader market this year.
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.
